Folotyn Medication Information
Adults who have been diagnosed with a certain type of cancer that affects blood cells of the immune system may benefit from Folotyn® (pralatrexate). This prescription medicine is specifically approved for the treatment of peripheral T-cell lymphoma when the cancer has come back or has not responded adequately to other treatment.
Folotyn is given as an intravenous (IV) injection once a week for six weeks, followed by a one-week break. This seven-week treatment cycle is continued as long as the medication is effective and you are not developing serious side effects. Your dosage will be based on your height and weight, other medications you are taking, and various other factors.
Before beginning chemotherapy treatment with Folotyn, make sure to review the medication's safety information with your healthcare provider. For example, you may not be able to use this medicine if you have low blood cell counts, kidney disease, or certain other medical issues. Also, this drug may react with various other products.
(For more information on this chemotherapy treatment, click Folotyn. This article offers an in-depth overview of this medication, including how it works, details on its safety and effectiveness, and possible side effects.)